Lycia Therapeutics, Inc (LYCA) Stock
Key stats
- Market cap
- $1.64B
- Price / Earnings ratio
- -44.7x
- EPS (TTM)
- -$2.59
- Volume
- Loading
- 52-week high
- $36.49
- 52-week low
- $22.19
Source: third-party data provider, as of November 13, 2026
Recent news
News tone: automated (AI) classification of the article's content, not a price prediction.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news
News tone: automated (AI) classification of the article's content, not a price prediction.
About Lycia Therapeutics, Inc
Lycia Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -12.0 | +15.7 |




